Company Overview and News

 
Podcast | Sensex recovers 150 points off lows, Nifty above 10,700; banks fall

2018-05-16 moneycontrol
Equity benchmarks witnessed a volatile day of trade on Tuesday as confused investors looked for cues from Karnataka on the domestic side, while developments from Korea dominated the global cues.

 
RIL, ICICI Bank, HDFC twin drag Sensex 156 pts; Midcap index outperforms, HUL top gainer

2018-05-16 moneycontrol
The market ended volatile session lower on Wednesday, but recovered half of its losses amid continued uncertainty over the formation of government in Karnataka. Recovery in rupee post RBI's likely intervention and fall in crude oil prices also supported the market.

 
Closing Bell: Sensex dips 156 pts, Nifty ends below 10,800; RIL, ICICI, HDFC twin drag

2018-05-16 moneycontrol
Market Closing: Benchmark indices closed sharply lower on Wednesday as uncertainty remained over the formation of government in Karnataka.

 
Market Live: Sensex dips 100 pts; FMCG index jumps on HUL, ITC support

2018-05-16 moneycontrol
Century Plyboards Q4 results: The company has reported 35 percent decline in its Q4 net profit at Rs 36 crore, while revenue was up 11.4 percent at Rs 544.1 crore.

 
Market Live: Sensex trims losses on recovery in banks; rupee gains 27 paise after hitting 68.13/$

2018-05-16 moneycontrol
Earnings: Two-wheeler maker TVS Motor Company has reported a healthy growth of 30.6 percent year-on-year in profit at Rs 165.6 crore fro the quarter ended March 2018, but overall earnings barring revenue missed analyst expectations.

 
Market Live: Sensex, Nifty off day#39;s lows amid rupee recovery, fall in oil prices

2018-05-16 moneycontrol
Crude Oil Update: Oil prices fell, weighed down by ample supplies despite ongoing output cuts by producer cartel OPEC and looming US sanctions against major crude exporter Iran.

 
Gammon Infra jumps 18% as ICICI Bank acquires nearly 18% stake in Co

2018-05-16 moneycontrol
Share price of Gammon Infrastructure Projects advanced 18.3 percent intraday Wednesday as private lender ICICI Bank acquired nearly 18 percent stake in the company through invocation of pledged shares.

 
ICICI Bank acquires stake in Gammon Infrastructure

2018-05-16 freepressjournal.in
New Delhi : ICICI Bank has acquired nearly 18 per cent stake in Gammon Infrastructure Projects through invocation of pledged shares, reports PTI.

 
ICICI Bank acquires nearly 18% stake in Gammon Infrastructure

2018-05-15 livemint
New Delhi: ICICI Bank has acquired nearly 18% stake in Gammon Infrastructure Projects through invocation of pledged shares.

 
Recently-listed infrastructure IPOs unlikely to repeat disastrous history

2018-03-23 thehindubusinessline
Priya Kansara Infrastructure companies, which got listed between 2004 and 2011, have bruised their investors badly due to financial crisis, high interest rates and slowdown in domestic economy on one hand and asset-heavy business models of most companies on the other.

 
Gammon Infrastructure Projects Limited - Outcome of Board Meeting

2018-02-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Gammon Infrastructure Projects Limited - Updates

2018-02-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Gammon Infrastructure Projects Limited - Appointment

2018-02-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
What to Watch: Order win may boost Gammon Infrastructure

2018-02-01 thehindubusinessline
Gammon Infrastructure Projects in consortium with Gammon Engineers and Contractors Private Ltd has received a letter of award from the National Highways Authority of India for the rehabilitation and upgradation of road project in Odisha. The project has been awarded by the NHAI on a bid price of ₹577 crore. The construction period of the project is 910 days and the company has 40 per cent share in the consortium.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...